Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer

British Journal of Surgery

Volumn 98, Issue 3, 2011, Pages 418-426

  Swellengrebel, H A M ^a   Marijnen, C A M ^a,b   Verwaal, V J ^a   Vincent, A ^a   Heuff, G ^c   Gerhards, M F ^d   Van Geloven, A A W ^e   Van Tets, W F ^d   Verheij, M ^a   Cats, A ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Infection and Immunology   (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e TERGOOI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; RADIOSENSITIZING AGENT;

ACUTE DISEASE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RECTUM TUMOR;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 79251506648     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7315     Document Type: Article

References (41)

1. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M,. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000; 284: 1008-1015.
2. PÃhlman L, Glimelius B,. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990; 211: 187-195.
3. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al.,; Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
4. den Dulk M, Marijnen CA, Putter H, Rutten HJ, Beets GL, Wiggers T, et al., Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 2007; 246: 83-90.
5. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, et al., Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004; 72: 15-24.
6. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, et al., Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
7. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al.,; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
8. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al.,; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
9. Van Cutsem E, Hoff PM, Harper P, Bukowski RM, Cunningham D, Dufour P, et al., Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer 2004; 90: 1190-1197.
10. Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D,. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer 2007; 97: 1333-1337.
11. Rodica Maricela A, Minea LN, Isacu I, Tarlea A, Bacinschi X,. Concomitant radiochemotherapy for elder patients with stage II-III rectal cancer. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Orlando, 2007.
12. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, et al., Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2006; 66: 762-771.
13. Kim DY, Jung KH, Kim TH, Kim DW, Chang HJ, Jeong JY, et al., Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007; 67: 378-384.
14. Velenik V, Anderluh F, Oblak I, Strojan P, Zakotnik B,. Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial. Croat Med J 2006; 47: 693-700.
15. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, et al., Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006; 17: 246-251. (Pubitemid 43160113)
16. Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, et al., Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 346-353.
17. Dupuis O, Vie B, Lledo G, Hennequin C, Noirclerc M, Bennamoun M, et al., Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR Phase II Study. Oncology 2007; 73: 169-176.
18. Dunst J, Debus J, Rudat V, Wulf J, Budach W, Hoelscher T, et al., Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol 2008; 184: 450-456.
19. Kerr SF, Norton S, Glynne-Jones R,. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg 2008; 95: 1534-1540.
20. Bujko K, Nowacki MP, Kepka L, Oledzki J, Bebenek M, Kryj M,; Polish Colorectal Study Group. Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation. Colorectal Dis 2005; 7: 410-416.
21. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al., Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811-820.
22. Khoo AK, Skibber JM, Nabawi AS, Gurlek A, Youssef AA, Wang B, et al., Indications for immediate tissue transfer for soft tissue reconstruction in visceral pelvic surgery. Surgery 2001; 130: 463-469.
23. van Gijn W, Wouters MW, Peeters KC, van de Velde CJ,. Nationwide outcome registrations to improve quality of care in rectal surgery. An initiative of the European Society of Surgical Oncology. J Surg Oncol 2009; 99: 491-496.
24. Matthiessen P, Hallböök O, RutegÃrd J, Simert G, Sjödahl R,. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 2007; 246: 207-214.
25. Heald RJ,. Rectal cancer: the surgical options. Eur J Cancer 1995; 31A: 1189-1192.
26. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 2006; [accessed 1 March 2008].
27. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
28. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
29. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al., The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-196.
30. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al., Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
31. Sobin LH, Wittekind CH,. International Union Against Cancer (UICC). TNM Classification on Malignant Tumours (5th edn). Wiley-Liss: New York, 1997.
32. Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, et al.,; EORTC Radiotherapy Group. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004; 40: 219-224.
33. Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, Pahlman L, et al., Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-3694.
34. Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, et al.,; Cooperative Investigators of the Dutch Colorectal Cancer Group. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002; 20: 817-825.
35. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-987.
36. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al., Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396.
37. Tan WS, Tang CL, Shi L, Eu KW,. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg 2009; 96: 462-472.
38. Hüser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J, et al., Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg 2008; 248: 52-60.
39. den Dulk M, Marijnen CA, Collette L, Putter H, PÃhlman L, Folkesson J, et al., Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg 2009; 96: 1066-1075.
40. Stone HB, Coleman CN, Anscher MS, McBride WH,. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003; 4: 529-536.
41. Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, et al., Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 2010; 147: 339-351.